J Korean Surg Soc.
1998 Jun;54(6):810-816.
Study of the Relation between Rreduced E-cadherin Expression and Known Prognostic Factors in Breast Cancer
- Affiliations
-
- 1Department of Surgery, College of Medicine, Dankook University.
- 2Department of Pathology, College of Medicine, Dankook University.
Abstract
- Breast Cancer in women poses a problem, and it can be difficult at times to evaluate the possibility of the cancer's recurrence in node negative early cancer. Reliable prognostic markers are needed in breast-cancer management to help clinicians identify patient with high risk of recurrence and arrive at more rational decisions for proper treatment. E-cadherin is a glycoprotein that mediates Ca2 -dependent cell-cell adhesion and maintenance of the epithelial cell phenotype. It has been implicated as an invasion-suppressing protein in experimental systems and in human tumors, and alterations in the cadherin function have been implicated in tumor progression in a number of adenocarcinomas. In this study, the expression of E-cadherin was reduced in 35.3% of the case reviewed(12/34), and we could find no clinical relation between the known prognostic factors except tumor stage(p<0.05), and the degree of E-cadherin expression.
Keyword
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- Expression of E-cadherin and Clinical Correlation in Patients with Breast Carcinoma
- Expression of E-cadherin according to the Presence of High Risk Prognostic Factors, Clinical Stages and Pathologic Types in Cervical Cancer Patients Treated by Radical Hysterectomy
- Expression of the nm23 and E-cadherin Proteins in Breast Carcinoma
- The Expression of Phospholipase C-gamma1 and Its Cellular Characteristics
- Prognostic Significance of E-cadherin Expression in Renal Cell Carcinoma
